{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/13/3344342/0/en/biomea-fusion-announces-first-patient-dosed-in-opal-study-evaluating-icovamenib-in-combination-with-semaglutide-in-obesity.html", "message": "News view counter 880591 successfully enlarged"}